Onset and course of chronic inflammatory demyelinating polyneuropathy

Muscle and Nerve

Volumn 31, Issue 5, 2005, Pages 589-593

  Mygland, A ^a,b   Monstad, P ^a   Vedeler, C ^c  

^a Sørlandet Sykehus ^*  (Norway)

^b Spesialsykehuset for Rehabilitering HF   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Chronic inflammatory demyelinating polyneuropathy; Clinical course; Immunosuppressive treatment; Nerve conduction; Terminal latency index

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; DEMYELINATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MALE; MUSCLE WEAKNESS; NERVE CONDUCTION; PHENOTYPE; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS;

ACUTE DISEASE; ADULT; AGE OF ONSET; AGED; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; NEURAL CONDUCTION; PERIPHERAL NERVES; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE;

EID: 17744386728     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20297     Document Type: Article

References (15)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-618.
2. Barohn RJ, Kissel JT, Warmolts JK, Mendell JK. Chronic inflammatory demyelinating polyneuropathy. Clinical characteristics, course, and recommendation for diagnostic criteria. Arch Neurol 1989;46:478-484.
3. Bouchard C, Lacroix C, Planté V, Adams D, Chedru F, Guglielmi JM, et al. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 1999;52:498-503.
4. Hughes R, Sanders E, Hall S, Atkinson P, Colchester A, Payan P. Subacute idiopathic demyelinating polyradiculoneuropathy. Arch Neurol 1992;49:612-616.
5. Kaku DA, England JD, Sumner AJ. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 1994;117:941-947.
6. Kuwabara S, Ogawara K, Misawa S, Mori M, Hattori T. Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2002;72:37-42.
7. Mygland Å, Monstad P. Chronic acquired demyelinating symmetric polyneuropathy classified by pattern of weakness. Arch Neurol 2003;60:260-264.
8. Oh SJ, Kurokawa K, de Almeida DF, Ryan HF, Claussen GC. Subacute inflammatory demyelinating polyneuropathy. Neurology 2003;61:1507-1512.
9. Olsson Y. Topographical differences in the vascular permeability of the peripheral nervous system. Acta Neuropathol 1968;10:26-33
10. Pollard JD. Chronic inflammatory demyelinating polyradiculoneuropathy. Curr Opin Neurol 2002;15:279-283.
11. Simmons Z, Albers JW. Chronic inflammatory demyelinating polyradiculoneuropathy and related disorders. In: Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro BE, editors. Neuromuscular disorders in clinical practice. Boston: Butterworth Heinemann; 2002. p 567-588.
12. Simmons Z, Albers JW, Bromberg MB, Feldman EL. Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy. Brain 1995;118:359-368.
13. Simmons Z, Albers JW, Bromberg MB, Feldman EL. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Comparison of patients without and with monoclonal gammopathy. Neurology 1993;43:2202-2209.
14. van Swieten JC, Koudstaal MD, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607.
15. Wijdicks EFM, Ropper AH. Acute relapsing Guillain-Barré syndrome after long asymptomatic intervals. Arch Neurol 1990;47:82-84.